Zacks Investment Research on MSN
Inogen (INGN) up 6.8% since last earnings report: Can it continue?
A month has gone by since the last earnings report for Inogen (INGN). Shares have added about 6.8% in that time frame, outperforming the S&P 500. But investors have to be wondering, will the recent ...
The financial regulations require hedge funds and wealthy investors that exceeded the $100 million holdings threshold to file a report that shows their positions at the end of every quarter. Even ...
Jacob Fund is a mutual fund company, released its third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The latest quarter showed continued market recovery, with major ...
Inogen, Inc. INGN recently completed the acquisition of Physio-Assist SAS. Following the close of the transaction (earlier announced on Jul 13, 2023), Inogen owns Physio-Assist and will now market the ...
Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a ...
Inogen (INGN) shares soared 6.6% in the last trading session to close at $6.13. The move was backed by solid volume with far more shares changing hands than in a normal session. This compares to the ...
SAN FRANCISCO (MarketWatch) -- Introgen Therapeutics Inc. said Wednesday a preclinical study with INGN 241 in combination with Avastin showed "synergistic activity" resulting in "a curative ...
Medical Technology company Inogen Inc (NASDAQ:INGN) reported a fourth-quarter adjusted EPS loss of 24 cents, compared to a loss of 83 cents a year ago, beating the consensus loss of 61 cents. The ...
A downtrend has been apparent in Inogen (INGN) lately with too much selling pressure. The stock has declined 10% over the past four weeks. However, given the fact that it is now in oversold territory ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results